ASA Biopharm's Podcast

In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.

http://community.amstat.org/BioP/Home/

Eine durchschnittliche Folge dieses Podcasts dauert 41m. Bisher sind 70 Folge(n) erschienen. Alle 4 Wochen erscheint eine Folge dieses Podcasts
subscribe
share



 

Episode 69: Non-proportional Hazards


Keaven Anderson, Pralay Mukhopadhyay, and Satrajit Roychoudhury discuss non-proportional hazards in a regulatory setting.


share





   50m
 
 

Episode 68: 2019 Regulatory-Industry Statistics Workshop


Judy Li and Renee Rees discuss what's new and exciting at the 2019 Regulatory-Industry Statistics Workshop.


share





 2019-08-30  44m
 
 

Episode 67: Task Force on Sexual Harassment and Assault


Donna LaLonde, Kristian Lum, and Leslie McClure discuss the ASA Task Force on Sexual Harassment and Assault.


share





 2019-07-30  51m
 
 

Episode 66: Quality Tolerance Limits


Rakhi Kilaru and Olgica Klindworth discuss risk-based monitoring and quality tolerance limits. 


share





 2019-06-28  40m
 
 

Episode 65: Immuno-oncology


Inna Perevozskaya and Bo Huang discuss the changing landscape in oncology clinical development. 


share





 2019-05-31  46m
 
 

Episode 64: Biopharmaceutical Software Scientific Working Group


Alex Dmitrienko and Kyle Wathen talk about the development of software for biopharmaceutical applications, the new working group and


share





 2019-04-30  52m
 
 

Episode 63: Platform Trials


Zoran Antonijevic, Robert Beckman, Scott Berry & Richard Simon discuss the current application and future of platform trials.  


share





 2019-03-29  56m
 
 

Episode 62: Qi Tang


Qi talks about the benefits and challenges of applying deep learning methodologies to electronic medical records.


share





 2019-02-28  42m
 
 

Episode 61: Richard C. Zink


Richard discusses the importance of the Biopharmaceutical Section and describes what he hopes to accomplish as Chair in 2019.


share





 2019-01-31  53m
 
 

Episode 60: Toshimitsu Hamasaki


Toshimitsu Hamasaki describes his work at a major research hospital and discusses the regulatory environment in Japan.


share





 2018-12-31  28m